| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 142217-69-4 | 恩替卡韋; 9-(4-羥基-3-羥甲基-2-亞甲基環(huán)戊-1-基)鳥(niǎo)嘌呤 | Entecavir; 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |  | C12H15N5O3 | 詳情 | 供應(yīng)商 |
| 113400-00-3 | 1H-Purine-2,6-dione,7-acetyl-3,7-dihydro-1,3-dimethyl-8-(2-propen-1-ylamino)-; 1H-Purine-2,6-dione,7-acetyl-3,7-dihydro-1,3-dimethyl-8-(2-propenylamino)- (9CI) |  | C12H15N5O3 | 詳情 | 供應(yīng)商 | |
| 114199-21-2 | 1H-Imidazo[1,2-a]purinium,9-hydroxy-3-[(2-hydroxyethoxy)methyl]-1,6-dimethyl-, inner salt |  | C12H15N5O3 | 詳情 | 供應(yīng)商 | |
| 100139-31-9 | 2-Quinazolinepropanoicacid, 3-amino-3,4-dihydro-8-methoxy-4-oxo-, hydrazide; 2-Quinazolinepropionicacid, 3-amino-3,4-dihydro-8-methoxy-4-oxo-, hydrazide (6CI) |  | C12H15N5O3 | 詳情 | 供應(yīng)商 | |
| 138571-54-7 | 3-Cyclopentene-1,2-diol,5-(6-amino-9H-purin-9-yl)-3-[(1R)-1-hydroxyethyl]-, (1S,2R,5R)-; 3-Cyclopentene-1,2-diol,5-(6-amino-9H-purin-9-yl)-3-(1-hydroxyethyl)-, [1S-[1a,2a,3(S*),5b]]-; TJ 13025 |  | C12H15N5O3 | 詳情 | 供應(yīng)商 | |
| 140440-46-6 | 6H-Purin-6-one,2-amino-9-[(1R,4S,5R)-4,5-bis(hydroxymethyl)-2-cyclopenten-1-yl]-1,9-dihydro-,rel-; 6H-Purin-6-one,2-amino-9-[4,5-bis(hydroxymethyl)-2-cyclopenten-1-yl]-1,9-dihydro-, (1a,4a,5b)- (9CI); 6H-Purin-6-one,2-amino-9-[4,5-bis(hydroxymethyl)-2-cyclopenten-1-yl]-1,9-dihydro-, (1a,4a,5b)-(?à)- |  | C12H15N5O3 | 詳情 | 供應(yīng)商 | |
| 114199-20-1 | 9H-Imidazo[1,2-a]purin-9-one,3,5-dihydro-3-[(2-hydroxyethoxy)methyl]-5,6-dimethyl- |  | C12H15N5O3 | 詳情 | 供應(yīng)商 |